65121-95-1

Usage

Uses

Used in Pharmaceutical Industry:
2,2'-iminobisethyl diacetate serves as a crucial reagent in the production of pharmaceuticals, facilitating the synthesis of various medicinal compounds due to its unique chemical structure and properties.
Used in Resin Production:
In the manufacturing of resins, 2,2'-iminobisethyl diacetate acts as a valuable component, contributing to the formation of specific types of resins with desired characteristics for use in coatings, adhesives, and composite materials.
Used in Polymer Synthesis:
2,2'-iminobisethyl diacetate is utilized as a monomer or a reactant in the synthesis of polymers, playing a key role in the development of polymers with specific properties for applications in plastics, films, fibers, and other materials.
Used as a Solvent:
Owing to its solubility and mild properties, 2,2'-iminobisethyl diacetate is employed as a solvent in various industrial processes, particularly in applications where a colorless and odorless solvent is required.
Used in Fragrance Industry:
The mild, fruity odor of 2,2'-iminobisethyl diacetate makes it suitable for use in the fragrance industry, where it can be incorporated into perfumes, colognes, and other scented products to provide a pleasant aroma.
Used in Cosmetics and Personal Care Products:
Given its low toxicity and good solubility, 2,2'-iminobisethyl diacetate can be used in the formulation of cosmetics and personal care products, such as creams, lotions, and shampoos, where it may contribute to the product's texture, stability, or other properties.

Upstream product

• 1041434-05-2 tert-butyl bis(2-acetoxyethyl)carbamate 

Downstream Products

• 1041434-15-4 N¹,N¹,N³,N³-tetrakis[2-(acetoxy)ethyl]5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isophthalamide 

Relevant academic research and scientific papers

Tailoring a bacteriochlorin building block with cationic, amphipathic, or lipophilic substituents

(Chemical Equation Presented) Bacteriochlorins are attractive candidates for photodynamic therapy (PDT) of diverse medical indications owing to their strong absorption in the near-infrared (NIR) region, but their use has been stymied by lack of access to stable, synthetically malleable molecules. To overcome these limitations, a synthetic free base 3,13-dibromobacteriochlorin (BC-Br3Br13) has been exploited as a building block in the synthesis of diverse bacteriochlorins via Pd-mediated coupling reactions (Sonogashira, Suzuki, and reductive carbonylation). Each bacteriochlorin is stable to adventitious dehydrogenation by virtue of the presence of a geminal dimethyl group in each pyrroline ring. The target bacteriochlorins bear cationic, lipophilic, or amphipathic substituents at the 3- and 13- (β-pyrrolic) positions. A dicarboxybacteriochlorin was converted to amide derivatives via the intermediate diacid chloride. A diformylbacteriochlorin was subjected to reductive amination to give aminomethyl derivatives. A set of 3,5-disubstituted aryl groups bearing lipophilic or amphipathic groups was introduced via Suzuki coupling. Altogether 22 free base bacteriochlorins have been prepared. Eight aminoalkylbacteriochlorins were quaternized with methyl iodide at two or four amine sites per molecule, which resulted in water solubility. Each bacteriochlorin exhibits a Qy absorption band in the range of 720-772 nm. The ability to introduce a wide variety of peripheral functional groups makes these bacteriochlorins attractive candidates for diverse applications in photomedicine including PDT in the NIR region.

Synthesis and antitumor activity of novel paclitaxel-chlorambucil hybrids

The syntheses and antitumor activity of three paclitaxel-chlorambucil hybrids are presented. Hybrid 3 showed significant in vivo efficacy.